U.S. markets open in 4 hours 34 minutes
  • S&P Futures

    3,787.00
    +24.75 (+0.66%)
     
  • Dow Futures

    30,869.00
    +149.00 (+0.49%)
     
  • Nasdaq Futures

    12,925.25
    +123.00 (+0.96%)
     
  • Russell 2000 Futures

    2,145.90
    +25.10 (+1.18%)
     
  • Crude Oil

    52.52
    +0.16 (+0.31%)
     
  • Gold

    1,842.70
    +12.80 (+0.70%)
     
  • Silver

    25.38
    +0.51 (+2.07%)
     
  • EUR/USD

    1.2124
    +0.0041 (+0.34%)
     
  • 10-Yr Bond

    1.0970
    0.0000 (0.00%)
     
  • Vix

    23.13
    -0.12 (-0.52%)
     
  • GBP/USD

    1.3607
    +0.0020 (+0.15%)
     
  • USD/JPY

    104.0280
    +0.3410 (+0.33%)
     
  • BTC-USD

    37,210.35
    +768.61 (+2.11%)
     
  • CMC Crypto 200

    733.84
    -1.30 (-0.18%)
     
  • FTSE 100

    6,735.31
    +14.66 (+0.22%)
     
  • Nikkei 225

    28,633.46
    +391.25 (+1.39%)
     

Global Pediatric Interventional Cardiology Devices Industry

ReportLinker
·24 min read

Global Pediatric Interventional Cardiology Devices Market to Reach $2. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Pediatric Interventional Cardiology Devices estimated at US$1.

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pediatric Interventional Cardiology Devices Industry" - https://www.reportlinker.com/p05957652/?utm_source=GNW
8 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transcatheter Heart Valves segment is readjusted to a revised 5.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $487 Million, While China is Forecast to Grow at 8.2% CAGR

The Pediatric Interventional Cardiology Devices market in the U.S. is estimated at US$487 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$537.6 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Other Segments Segment to Record 3.9% CAGR

In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$200.2 Million in the year 2020 will reach a projected size of US$255.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$346.3 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Cardinal Health, Inc.

  • Edwards Lifesciences Corporation

  • GE Healthcare

  • Medtronic PLC

  • Numed Inc.

  • Siemens AG

  • W. L. Gore & Associates, Inc.




Read the full report: https://www.reportlinker.com/p05957652/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Pediatric Interventional Cardiology Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Pediatric Interventional
Cardiology Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 3: World 15-Year Perspective for Pediatric Interventional
Cardiology Devices by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Congenital Heart
Defect Closure Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027

Table 5: World Historic Review for Congenital Heart Defect
Closure Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 6: World 15-Year Perspective for Congenital Heart Defect
Closure Devices by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Transcatheter
Heart Valves by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 8: World Historic Review for Transcatheter Heart Valves
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for Transcatheter Heart
Valves by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 10: World Current & Future Analysis for Other Segments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for Other Segments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 12: World 15-Year Perspective for Other Segments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Pediatric Interventional Cardiology Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 13: USA Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 14: USA Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 15: USA 15-Year Perspective for Pediatric Interventional
Cardiology Devices by Segment - Percentage Breakdown of Value
Sales for Congenital Heart Defect Closure Devices,
Transcatheter Heart Valves and Other Segments for the Years
2012, 2020 & 2027

CANADA
Table 16: Canada Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 17: Canada Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 18: Canada 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

JAPAN
Table 19: Japan Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 20: Japan Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 21: Japan 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

CHINA
Table 22: China Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 23: China Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 24: China 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Pediatric Interventional Cardiology Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 25: Europe Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 26: Europe Historic Review for Pediatric Interventional
Cardiology Devices by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 27: Europe 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets for Years 2012,
2020 & 2027

Table 28: Europe Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 29: Europe Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 30: Europe 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

FRANCE
Table 31: France Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 32: France Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 33: France 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

GERMANY
Table 34: Germany Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 35: Germany Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 36: Germany 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

ITALY
Table 37: Italy Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 38: Italy Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 39: Italy 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

UNITED KINGDOM
Table 40: UK Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 41: UK Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 42: UK 15-Year Perspective for Pediatric Interventional
Cardiology Devices by Segment - Percentage Breakdown of Value
Sales for Congenital Heart Defect Closure Devices,
Transcatheter Heart Valves and Other Segments for the Years
2012, 2020 & 2027

SPAIN
Table 43: Spain Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 44: Spain Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 45: Spain 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

RUSSIA
Table 46: Russia Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 47: Russia Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 48: Russia 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

REST OF EUROPE
Table 49: Rest of Europe Current & Future Analysis for
Pediatric Interventional Cardiology Devices by Segment -
Congenital Heart Defect Closure Devices, Transcatheter Heart
Valves and Other Segments - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 50: Rest of Europe Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 51: Rest of Europe 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 52: Asia-Pacific Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027

Table 53: Asia-Pacific Historic Review for Pediatric
Interventional Cardiology Devices by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 54: Asia-Pacific 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Geographic Region -
Percentage Breakdown of Value Sales for Australia, India, South
Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 &
2027

Table 55: Asia-Pacific Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 56: Asia-Pacific Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 57: Asia-Pacific 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

AUSTRALIA
Table 58: Australia Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 59: Australia Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 60: Australia 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

INDIA
Table 61: India Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 62: India Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 63: India 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

SOUTH KOREA
Table 64: South Korea Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 65: South Korea Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 66: South Korea 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 67: Rest of Asia-Pacific Current & Future Analysis for
Pediatric Interventional Cardiology Devices by Segment -
Congenital Heart Defect Closure Devices, Transcatheter Heart
Valves and Other Segments - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 68: Rest of Asia-Pacific Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 69: Rest of Asia-Pacific 15-Year Perspective for
Pediatric Interventional Cardiology Devices by Segment -
Percentage Breakdown of Value Sales for Congenital Heart Defect
Closure Devices, Transcatheter Heart Valves and Other Segments
for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 70: Latin America Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Geographic Region -
Argentina, Brazil, Mexico and Rest of Latin America Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 71: Latin America Historic Review for Pediatric
Interventional Cardiology Devices by Geographic Region -
Argentina, Brazil, Mexico and Rest of Latin America Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 72: Latin America 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Geographic Region -
Percentage Breakdown of Value Sales for Argentina, Brazil,
Mexico and Rest of Latin America Markets for Years 2012, 2020 &
2027

Table 73: Latin America Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 74: Latin America Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 75: Latin America 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

ARGENTINA
Table 76: Argentina Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 77: Argentina Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 78: Argentina 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

BRAZIL
Table 79: Brazil Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 80: Brazil Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 81: Brazil 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

MEXICO
Table 82: Mexico Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 83: Mexico Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 84: Mexico 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

REST OF LATIN AMERICA
Table 85: Rest of Latin America Current & Future Analysis for
Pediatric Interventional Cardiology Devices by Segment -
Congenital Heart Defect Closure Devices, Transcatheter Heart
Valves and Other Segments - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 86: Rest of Latin America Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 87: Rest of Latin America 15-Year Perspective for
Pediatric Interventional Cardiology Devices by Segment -
Percentage Breakdown of Value Sales for Congenital Heart Defect
Closure Devices, Transcatheter Heart Valves and Other Segments
for the Years 2012, 2020 & 2027

MIDDLE EAST
Table 88: Middle East Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Geographic Region - Iran,
Israel, Saudi Arabia, UAE and Rest of Middle East Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 89: Middle East Historic Review for Pediatric
Interventional Cardiology Devices by Geographic Region - Iran,
Israel, Saudi Arabia, UAE and Rest of Middle East Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 90: Middle East 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Geographic Region -
Percentage Breakdown of Value Sales for Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets for Years 2012,
2020 & 2027

Table 91: Middle East Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 92: Middle East Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 93: Middle East 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

IRAN
Table 94: Iran Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 95: Iran Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 96: Iran 15-Year Perspective for Pediatric Interventional
Cardiology Devices by Segment - Percentage Breakdown of Value
Sales for Congenital Heart Defect Closure Devices,
Transcatheter Heart Valves and Other Segments for the Years
2012, 2020 & 2027

ISRAEL
Table 97: Israel Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 98: Israel Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 99: Israel 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

SAUDI ARABIA
Table 100: Saudi Arabia Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 101: Saudi Arabia Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 102: Saudi Arabia 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

UNITED ARAB EMIRATES
Table 103: UAE Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 104: UAE Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 105: UAE 15-Year Perspective for Pediatric Interventional
Cardiology Devices by Segment - Percentage Breakdown of Value
Sales for Congenital Heart Defect Closure Devices,
Transcatheter Heart Valves and Other Segments for the Years
2012, 2020 & 2027

REST OF MIDDLE EAST
Table 106: Rest of Middle East Current & Future Analysis for
Pediatric Interventional Cardiology Devices by Segment -
Congenital Heart Defect Closure Devices, Transcatheter Heart
Valves and Other Segments - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 107: Rest of Middle East Historic Review for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 108: Rest of Middle East 15-Year Perspective for
Pediatric Interventional Cardiology Devices by Segment -
Percentage Breakdown of Value Sales for Congenital Heart Defect
Closure Devices, Transcatheter Heart Valves and Other Segments
for the Years 2012, 2020 & 2027

AFRICA
Table 109: Africa Current & Future Analysis for Pediatric
Interventional Cardiology Devices by Segment - Congenital Heart
Defect Closure Devices, Transcatheter Heart Valves and Other
Segments - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 110: Africa Historic Review for Pediatric Interventional
Cardiology Devices by Segment - Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019

Table 111: Africa 15-Year Perspective for Pediatric
Interventional Cardiology Devices by Segment - Percentage
Breakdown of Value Sales for Congenital Heart Defect Closure
Devices, Transcatheter Heart Valves and Other Segments for the
Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 41
Read the full report: https://www.reportlinker.com/p05957652/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001